← Back
$ANTX All transactions

AN2 Therapeutics, Inc.

▼ SELL

$ Value

$3K

Shares

2,819

Price

$1

Filed

Nov 6

Insider

Name

Eizen Joshua M

Title

See Remarks

CIK

0001949621

Roles

Officer

Transaction Details

Transaction Date

2025-11-04

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

177,353

Footnotes

Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on November 4, 2025. | Includes, in accordance with the original terms, (a) 31,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024 (b) 22,500 RSUs which vest as follows: 1/3rd of the RSUs vest annually over three years from January 1, 2025 and (c) 45,000 RSUs which vest as follows: 2/3rd of the RSUs vest on January 1, 2026 and 1/3rd of the RSUs vest on July 1, 2026, subject to the Reporting Person's continuous service as of such date. | Reflects the adjusted total which includes the purchase of 5,000 shares under the Issuer's 2022 Employee Stock Purchase Plan on September 30, 2025.

Filing Info

Accession No.

0001193125-25-270255

Form Type

4

Issuer CIK

0001880438

Eizen Joshua M's History

Date Ticker Type Value
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-02-20 ANTX A $0
2026-02-20 ANTX A $0
2026-01-06 ANTX $7K
2026-01-05 ANTX $18K
2025-11-04 ANTX $3K

Other Insiders at ANTX (90d)

Insider Bought Sold Last
Zakrzewski Joseph S 2026-03-19
Spigelman Melvin K 2026-03-19
Wong Stephanie 2026-03-19
Chanda Sanjay
Chief Development Officer
2026-03-19
FitzPatrick Margaret M 2026-03-19
Easom Eric
Chief Executive Officer
2026-03-19
Day Lucy
Chief Financial Officer
2026-03-19
Aziz Kabeer 2026-04-10
Readnour Robin Shane 2026-03-19
Martin Patricia A. 2026-04-10
Marks Gilbert Lynn 2026-04-10
Eizen Joshua M
See Remarks
2026-03-19
Williams Sarah Joanne
Principal Accounting Officer
$347 2026-03-03